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Abstract We have previously described an estrogen inducible, 
intracellular, homodimeric membrane glycoprotein (subunit MT 
104 kDa) which is structurally related to 'chaperone' proteins 
(Poola, I. and Kiang J.G., J. Biol. Chem. 269 (1994) 21762-
21769). In this report we describe a novel finding that the 104 
kDa chaperone protein exhibits affinity for iron containing 
proteins such as transferrins from several species, human 
lactoferrin and microbial ferric binding protein (FBP). A single 
ferric ion in the above proteins appears to be sufficient for 
binding. It also binds to immobilized ferritin. However, it does 
not exhibit any affinity for apotransferrins, apolactoferrin, 
apoferritin and apoFBP. This is the first report of a chaperone 
protein that exhibits affinity for iron containing proteins. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
We have previously described the purification and charac-
terization of an estrogen inducible membrane glycoprotein 
(EIMG) from chicken oviduct membranes. It is an intracellu-
lar disulfide linked homodimeric protein with a subunit Mx of 
104 kDa. A 116 kDa polypeptide which is structurally related 
to the 104 kDa subunit was also isolated. Amino acid se-
quence analysis of proteolytic peptides showed that EIMG 
is structurally related to the 'chaperone' (stress regulated) pro-
teins, chicken heat shock protein 108 (hspl08), hamster glu-
cose regulated proteins (hagrp94), human tumor rejection 
antigen (hTRAgp96), and mouse endoplasmic reticular pro-
tein (mERp99). All of these proteins are shown to be highly 
homologous to each other and to yeast hsp90. Stress induc-
tion experiments showed that EIMG is induced after a pro-
longed heat treatment [1,2]. The chaperone functions of glu-
cose regulated proteins and tumor rejection antigens have 
been previously investigated. It was reported that glucose 
regulated proteins are involved in protein folding, similar to 
hsp70 [3], and the tumor rejection antigens are involved in 
presenting antigenic peptides to MHC class I molecules [4]. 
They are also implicated in protein folding [5,6]. However, no 
function has been described for hspl08 thus far. 
In the present study, we report a novel finding that EIMG 
binds ferric iron loaded transferrins from several species, hu-
man lactoferrin and microbial ferric binding protein (FBP). 
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We demonstrate here that ferric ions are essential for binding 
of EIMG to the above proteins. EIMG affinity for iron con-
taining proteins, structural homologies with chaperone pro-
teins and intracellular localization suggest that it is probably 
involved in intracellular trafficking of iron. 
2. Materials and methods 
Human transferrin, human lactoferrin, bovine transferrin, mouse 
transferrin, ovotransferrin, protease inhibitors, aprotinin, pepstatin, 
leupeptin, chymostatin and PMSF, concanavalin A-Sepharose 4B, 
human hemoglobin, chicken heart cytochrome c, horse ferritin and 
apoferritin, casein agarose, gelatin agarose, histone agarose, fetuin 
agarose, thyroglobin agarose, lysozyme agarose, immunoglobulin 
agarose and trypsin were obtained from Sigma Chemical Company. 
Affi-Gel 10 and sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis (SDS-PAGE) molecular weight standards were from Bio-
Rad. Rabbit polyclonal antibodies against full length EIMG were 
available from previous studies [2]. Hen oviduct membranes were 
prepared as described [7]. They were first washed with 0.1 M citrate 
buffer pH 5.0, followed by 0.1 M glycine-NaOH buffer, pH 10.0 and 
finally with 50 mM Tris-HCl pH 7.6 in cold 4°C to diminish the 
endogenous ovotransferrin. FBP, isolated from Haemophilus influen-
zae, was kindly provided by Dr. Timothy Mietzner, Department of 
Molecular Genetics and Biochemistry, University of Pittsburgh 
School of Medicine, Pittsburgh, PA. 
2.1. Preparation of immobilized transferrins, lactoferrin, FBP, ferritins, 
hemoglobin and cytochrome c 
Five milligrams of each of the above proteins were immobilized to 
1 ml of Affi-Gel 10 according to the manufacturer's directions. Affi-
Gel 10 transferrins, Affi-Gel 10 lactoferrin and Affi-Gel 10 FBP were 
first washed with 0.1 M citrate, pH 5.0 to remove all bound iron and 
were saturated with defined amounts of ferric iron according to a 
previously described procedure [8], 
2.2. Preparation of COOH-terminal and NHg-terminal lobes of human 
transferrin and their immobilization to Affi-Gel 
Transferrins are monomeric molecules of Mr 80 kDa, composed of 
two homologous regions [9] which were shown to have originated by 
gene duplication [10]. Previous studies have shown that each lobe 
reversibly binds one molecule of ferric ion and that the two iron 
binding half molecules could be isolated by trypsinization of iron 
saturated transferrin [11]. In the present study, the COOH-terminal 
and NH2-terminal lobes of human transferrin were isolated using the 
procedure described previously [12]. Briefly, iron saturated human 
transferrin (70 mg) was hydrolyzed with trypsin (4 mg) in 50 mM 
Tris-HCl buffer, pH 8.2 and 20 mM CaCl2 for 24 h at 37°C. It was 
chromatographed on a Sephadex-100 column to remove the undi-
gested transferrin from the COOH-terminal and NH2-terminal lobes. 
They were finally separated by affinity chromatography on concana-
valin A-Sepharose 4B as described [12]. The separated fractions were 
concentrated in Centriplus (Amicon) filters and immobilized to Affi-
Gel 10 as above. 
2.3. Binding of EIMG to immobilized transferrins, lactoferrin and FBP 
The following procedure was used to test the binding property of 
EIMG to transferrins of various species, human lactoferrin, and FBP : 
the washed hen oviduct membranes, which contain EIMG, were solu-
bilized by mild sonication in 100 mM Tris-HCl pH 7.6, 2% Triton X-
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100, 2 mM PMSF, and 2 (ig/ml each of the protease inhibitors leu-
peptin, pepstatin and aprotinin. The undissolved material was re-
moved by centrifugation in a refrigerated centrifuge at lOOOOXg. 
The clear supernatant (approximately 15 mg protein in 1 ml) was 
added to 1 ml each of Affi-Gel 10 transférons, Affi-Gel 10 lactoferrin, 
and Affi-Gel 10 FBP and rotated for 30 min at 4°C. The gels were 
loaded to columns and each column was washed with 200 ml of the 
solubilization buffer to remove all unbound proteins. Iron from trans-
ferrin, lactoferrin and FBP columns was removed by washing with 50 
ml of 0.1 M citrate buffer, pH 5.0, 0.2% Triton X-100 and protease 
inhibitors as above. Finally, bound EIMG was eluted from the affinity 
columns with 2 ml of 0.1 M glycine-NaOH buffer, pH 10.0, 5 mM 
EDTA, 0.2% Triton X-100, 50 itg/ml desferrioxamine and protease 
inhibitors as above. The eluate was adjusted to pH 7.0 and concen-
trated in an amicon microconcentrator to 100 (il and analyzed for 
EIMG by SDS-PAGE and Western blotting. All the Chromatographie 
procedures were conducted in a cold room. To test the contribution of 
iron for binding, oviduct membranes were solubilized and chromato-
graphed on immobilized apotransferrins, apolactoferrin, and apoFBP 
as above and in the presence of 10 mM EDTA and 50 |xg/ml desfer-
rioxamine to chelate trace amounts of iron in the buffer salts. Binding 
to immobilized ferric loaded and apo-human transferrin COOH-ter-
minal and NH2-terminal lobes was also conducted by the same pro-
cedures. 
2.4. Binding of EIMG to hemoglobin, cytochrome c and ferritins 
EIMG binding to these proteins was tested by the same procedure 
as above except that the citrate buffer wash was deleted. Binding to 
Affi-Gel 10 apoferritin was tested in the presence of 5 mM EDTA and 
50 ug/ml desferrioxamine similar to the procedure described for Affi-
Gel 10 apotransferrins. 
2.5. Binding of EIMG to proteins which do not contain iron 
To test whether EIMG shows any affinity for proteins which do not 
contain iron, oviduct membrane extract was chromatographed on the 
following immobilized proteins: casein agarose, gelatin agarose, his-
tone agarose, fetuin agarose, thyroglobin agarose, lysozyme agarose 
and immunoglobulin agarose. The immobilized proteins were allowed 
to interact with the oviduct membrane extract, loaded onto columns 
and washed with solubilization buffer (200 ml). The gels were finally 
eluted with 0.1 M glycine-NaOH, pH 10.0, 0.2% Triton-X 100, and 
protease inhibitors as above. The eluates were concentrated and ana-
lyzed for the presence of EIMG by SDS-PAGE and Western blotting. 
2.6. Electrophoresis and Western blotting 
SDS-PAGE (12%) was conducted in a Bio-Rad slab gel apparatus 
as described by Laemmli [13]. Proteins were transblotted to nitrocel-
lulose membranes as described by Towbin et al. [14]. Blocking and 
antibody treatments were performed as described [15]. A dilution of 
1:10000 anti-EIMG antibodies was used to probe the blots. The 
antigen-antibody complexes were detected using a 1:7500 dilution of 
the horseradish peroxidase conjugated goat anti-rabbit IgG and devel-
opment with the enhanced chemiluminescence (ECL, Amersham) de-
tection system. 
3. Results and discussion 
Previously an estrogen inducible membrane glycoprotein 
was identified and characterized in the chicken oviduct. Pro-
tein sequence analysis showed that it is structurally related to 
stress regulated proteins. Preliminary experiments indicated 
that it binds transferrin molecules. This was unexpected in 
light of its structural homologies (more than 95%) to chaper-
one proteins and less than 5% amino acid sequence homology 
with the chicken transferrin receptor. We have undertaken the 
current study to understand the transferrin binding property 
of EIMG. In this report, we describe a novel finding that 
EIMG binds ferric ion containing proteins. 
We used crude oviduct membrane extract which contains 
EIMG to test its binding property with immobilized diferric, 
monoferric, and apotransferrins, lactoferrin, microbial FBP, 
Fig. 1. Binding of estrogen inducible membrane glycoprotein to im-
mobilized diferric and apotransferrins and lactoferrin. The chicken 
oviduct membranes were solubilized and chromatographed on difer-
ric Affi-Gel 10 transferrins of various species, Affi-Gel 10 human 
lactoferrin, Affi-Gel 10 apotransferrins and Affi-Gel 10 human apo-
lactoferrin according to the procedures described in Section 2. The 
affinity columns were eluted, the eluates concentrated and analyzed 
for EIMG by SDS-PAGE and Western blotting. Lanes 1, 3, 5, 7 
and 9 contain the eluates from affinity gels of diferric transferrins 
from chicken, human, bovine, and mouse and human diferric lacto-
ferrin respectively. Lanes 2, 4, 6 and 10 contain the eluates from im-
mobilized apotransferrin affinity columns of chicken, human, bovine 
and mouse and human apolactoferrin, respectively. 
ferritin, hemoglobin and cytochrome c. The results of EIMG 
binding to diferric transferrins from several species and lacto-
ferrin are presented in Fig. 1. As seen in Fig. 1, EIMG binds 
to immobilized diferric transferrins of chicken, human, bovine 
and mouse equally well (Fig. 1, lanes 1, 3, 5, and 7 respec-
tively). We observed several very closely spaced bands on 
Western blots between MT 95 kDa and 104 kDa and a minor 
band at 116 kDa. We have previously shown that both 116 
kDa and 104 kDa species are proteolytically labile molecules 
and they give rise to several lower molecular weight species 
even in the presence of various protease inhibitors [2]. There-
fore, the closely spaced species of EIMG observed here are 
possibly proteolytically degraded species. EIMG also bound 
to immobilized diferric human lactoferrin, an iron binding 
protein from milk, which is structurally related to transferrins 
(Fig. 1, lane 9). The primary structures of transferrins of sev-
eral species and lactoferrin are elucidated. Comparison of the 
sequences of transferrins from different species and lactofer-
rins reveals that they share amino acid sequence homologies 
in the ferric binding region [16]. The affinity of EIMG to ferric 
loaded transferrins of several species and lactoferrin suggests 
that it recognizes the conserved amino acids in the ferric bind-
ing regions of transferrin and lactoferrin molecules. The trans-
ferrin and lactoferrin binding properties of EIMG described 
here are distinct from the ligand binding properties of the 
transferrin receptors. Unlike EIMG, transferrin receptors are 
species specific in that the receptors of one species do not bind 
the transferrins from a different species. Transferrin receptors 
also do not bind lactoferrin molecules [17]. 
To discern whether ferric ions or the conserved amino acids 
of transferrins are involved in the binding of EIMG, we con-
ducted binding experiments with immobilized (1) human 
transferrin which has 30% and 100% saturated ferric ions 
and (2) apotransferrins and apolactoferrin. Our results show 
that the amount of EIMG bound was more than doubled 
when the ferric ion saturation increased from 30 to 100% 
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Fig. 2. Binding of estrogen inducible membrane glycoprotein to im-
mobilized human transferrin loaded with different amounts of ferric 
ions. The chicken oviduct membranes were solubilized and chroma-
tographed on 30% and 100% iron saturated human transferrin affin-
ity columns according to the procedures described in Section 2. The 
affinity columns were eluted, the eluates concentrated and analyzed 
for EIMG by SDS-PAGE and Western blotting. Lane 1, eluate 
from immobilized human transferrin 30% with ferric iron; lane 2, 
eluate from immobilized human transferrin saturated 100% with fer-
ric iron. 
(Fig. 2, lanes 1 and 2 respectively), suggesting that ferric ions 
are involved in binding. This finding was further confirmed by 
the results obtained with apotransferrins. In sharp contrast to 
its high affinity for ferric transferrins, binding to immobilized 
apotransferrin and apolactoferrin affinity gels is totally absent 
(Fig. 1, lanes 2, 4, 6, 8, and 10). These findings clearly indicate 
that ferric ions are essential for the binding of EIMG to trans-
ferrins. After establishing that ferric ions are essential, we 
sought to determine whether two ferric ions are required or 
a single ferric ion is sufficient for binding. For this, we tested 
EIMG binding to immobilized monoferric COOH-, and Non-
terminal lobes of human transferrin. It bound to immobilized 
monoferric human transferrin half molecules (data not 
shown), indicating that a single ferric ion is sufficient for bind-
ing. EIMG did not bind to immobilized apoCOOH and NH2 
lobes of human transferrin, consistent with earlier results. 
The binding of EIMG to transferrins of various species and 
lactoferrin raised a question whether EIMG shows affinity for 
other ferric containing proteins which are not structurally 
related to transferrins or lactoferrins. To test the above, we 
conducted binding experiments with immobilized FBP iso-
lated from the microbe H. influenzae. The primary structure, 
ferric binding property and function of FBP are well docu-
mented. It is a polypeptide of Mr 34 kDa, which reversibly 
binds a single ferric ion per molecule of protein with high 
affinity. The functional role of FBP was shown to be the 
transport of ferric molecules across the 'extracytoplasmic' 
periplasmic space of prokaryotes [18]. Although both FBP 
and transferrins reversibly bind ferric ions, they share little 
similarity in amino acid sequence. However, the amino acids 
involved in binding ferric ions in FBP appear to be remark-
ably similar to transferrins [19]. To test the ability of EIMG 
to bind FBP, oviduct membrane extract was chromato-
graphed on immobilized monoferric FBP similar to transfer-
rin affinity gels. The bound material was analyzed by SDS-
PAGE and Western blotting. We detected EIMG (97 kDa-
105 kDa and 116 kDa bands) in the FBP bound fraction 
similar to the pattern observed in binding experiments with 
diferric transferrins and lactoferrin (Fig. 1) (data not shown). 
It did not show any affinity to apoFBP. 
The high affinity of EIMG observed for ferric containing 
proteins raised the question whether it has any affinity for 
other iron containing proteins which have irreversibly bound 
iron. For this, we conducted binding experiments with immo-
bilized ferritin, hemoglobin and cytochrome c. Ferritin has 
irreversibly bound iron in the oxidized state. Hemoglobin 
and cytochrome c have bound heme to which ferrous ions 
are coordinated. Our results show that EIMG bound to im-
mobilized ferritin but not to apoferritin, hemoglobin and cy-
tochrome c (data not shown). In similar experiments, EIMG 
did not show any binding to immobilized non-iron containing 
proteins, casein-agarose, gelatin-agarose, fetuin-agarose, thy-
roglobin-agarose, lysozyme-agarose, histone-agarose and im-
munoglobulin-agarose. The observations that EIMG did not 
bind hemoglobin and cytochrome c suggest two possibilities: 
the iron should be (1) bound directly to the protein molecule 
to be recognized by EIMG or (2) in the ferric state. EIMG 
binding to non-heme, ferrous containing proteins could not be 
tested because of their unavailability. 
The results described here are the first observations of a 
stress regulated protein exhibiting affinity for ferric containing 
proteins. The results presented above also indicate that EIMG 
is not specific to the protein molecule which carries the ferric 
iron since it binds transferrins of several species, lactoferrin, 
ferritin and FBP equally well. This is a novel observation 
since no other protein with such property has been described 
thus far. From the results above it appears that the ferric 
molecule is necessary for the binding between EIMG and 
the protein to which ferric iron is bound. It is not clear 
whether EIMG recognizes the ferric iron in the protein mol-
ecule or the conformation as modified by iron binding. The 
physiological implications of EIMG affinity for iron contain-
ing proteins are not clear. The intracellular location of EIMG 
excludes its participation in transferrm dependent, receptor 
mediated or transferrin independent iron uptake across the 
cell membrane. Iron uptake by the above two processes is 
described extensively [20-22]. However, the details of how 
ferric ions get transported intracellularly to target proteins 
are not known. Nunez et al. [23] have envisioned that it is 
an energy dependent, carrier mediated process through the 
transmembrane. However, there are no reports of such a 
transmembrane molecule which participates in the intracellu-
lar mobility of ferric ions until now. Since EIMG is an intra-
cellular membrane protein possessing affinity for ferric iron 
containing proteins, it is conceivable that EIMG may be in-
volved in facilitating the trafficking of ferric ions inside the 
cell. 
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